ANAVEX LIFE SCIENCES CORP.
For the period ended Jun 30, 2026. Filed Aug 28, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 28, 2026
AVXL$1.22+6.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
| Exhibit Number | Description |
| 3.1 | Articles of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to our Annual Report on Form 10-K for the year ended September 30, 2021 filed on November 24, 2021) |
| 3.2 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to our Current Report on Form 8-K filed on April 14, 2023) |
| 10.1*^ | Employment Agreement, dated May 4, 2026, by and between Anavex Life Sciences Corp. and Terrie Kellmeyer, Ph.D. |
| 31.1* | Certification of Terrie Kellmeyer, Ph.D. |
| 31.2* | Certification of Sandra Boenisch |
| 32.1** | Certification of Terrie Kellmeyer, PhD and Sandra Boenisch. |
| 101.INS* | XBRL INSTANCE DOCUMENT |
| 101.SCH* | XBRL TAXONOMY EXTENSION SCHEMA |
| 101.CAL* | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE |
| 101.DEF* | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE |
| 101.LAB* | XBRL TAXONOMY EXTENSION LABEL LINKBASE |
| 101.PRE* | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE |
- Filed herewith.
** Furnished herewith.
^ Indicates management contract or compensatory plan.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.